Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04281381 · ClinicalTrials.gov registry record
Observing People With Desmoid-Type Fibromatosis
A clinical trial of Desmoid Fibromatosis, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04281381: Recruiting study of Desmoid Fibromatosis, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04281381 is a study of Desmoid Fibromatosis that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04281381, a study of Desmoid Fibromatosis, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.
Primary Outcome
The primary objective of this study is to estimate progression-free survival at 12 months, with the events defined by progression via radiographic criteria (RECIST 1.1).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cross-sectional imaging
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2026-02-19 |
What NCT04281381 shows while recruiting
NCT04281381 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Desmoid Fibromatosis appearing as the primary indexed condition, and to 1 intervention - of which Cross-sectional imaging is the first listed.
NCT04281381 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04281381 about?
NCT04281381 is a clinical study titled "Observing People With Desmoid-Type Fibromatosis". The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.
What is the current status of trial NCT04281381?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2020-02-19. Estimated completion is 2026-02-19.
What conditions does trial NCT04281381 study?
This clinical trial studies the following conditions: Desmoid Fibromatosis.
What interventions are being tested in trial NCT04281381?
The interventions under investigation include: Cross-sectional imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04281381?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04281381 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Desmoid Fibromatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI